研究单位：[1]Chongqing Jiachen Biotechnology Ltd.[2]Beijing Youan Hosptial,Capital Medical University Beijing,Beijing,China[3]The Third People's Hosptial of Shenzhen Shenzhen,Guangdong,China[4]Renmin Hosptial of Wuhan University WuHan,Hubei,China[5]The Second Xiangya Hospital of Central South University Changsha,Hunan,China[6]Xiangya Hospital Central South University ChangSha,Hunan,China[7]81th Hospital of PLA NanJing,Jiangsu,China[8]Jiangsu Province Hospital NanJing,Jiangsu,China[9]The Second Hospital of Nanjing Nanjing,Jiangsu,China[10]First Affiliated Hospital of Kunming Medical University Kunming,Yunnan,China
研究目的：
The purpose is to evaluate efficacy and safety of therapeutic hepatitis B virus (HBV) vaccine (mimogen-based)) Joint entecavir treatment in chronic hepatitis B patients.
